N
1.50
-0.03 (-1.96%)
| Previous Close | 1.53 |
| Open | 1.54 |
| Volume | 81,780 |
| Avg. Volume (3M) | 65,048 |
| Market Cap | 12,214,701 |
| Price / Earnings (Forward) | 15.20 |
| Price / Sales | 1.03 |
| Price / Book | 2.48 |
| 52 Weeks Range | |
| Earnings Date | 11 Nov 2025 |
| Profit Margin | -30.70% |
| Operating Margin (TTM) | -27.69% |
| Diluted EPS (TTM) | -0.450 |
| Quarterly Revenue Growth (YOY) | 121.60% |
| Total Debt/Equity (MRQ) | 49.25% |
| Current Ratio (MRQ) | 1.88 |
| Operating Cash Flow (TTM) | -3.17 M |
| Levered Free Cash Flow (TTM) | -2.58 M |
| Return on Assets (TTM) | -20.77% |
| Return on Equity (TTM) | -60.08% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Mixed | |
| Stock | NexGel, Inc | Mixed | Mixed |
AIStockmoo Score
1.0
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 5.0 |
| Technical Oscillators | -2.5 |
| Average | 1.00 |
|
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Core |
| % Held by Insiders | 16.15% |
| % Held by Institutions | 8.43% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Simon Quick Advisors, Llc | 30 Sep 2025 | 35,715 |
| Flaharty Asset Management, Llc | 30 Sep 2025 | 24,000 |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 11 Dec 2025 | Announcement | NEXGEL Announces Spin-Off of Drug Delivery Program into NexGelRx |
| 11 Nov 2025 | Announcement | NEXGEL Reports Third Quarter 2025 Financial Results |
| 03 Nov 2025 | Announcement | NEXGEL to Report Third Quarter 2025 Financial Results on November 11th |
| 09 Oct 2025 | Announcement | NEXGEL to Present at the LD Micro Main Event XIX Conference on October 19-21 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |